Iron Infusion CPT Codes, Hierarchies & Denial Prevention
Infusion billing follows a strict hierarchy that most practices only half-understand, and the half they're missing costs real money. A single infusion visit can involve four or five CPT codes. Get the sequencing wrong and you're looking at a denial, a bundling edit, or worse, a take-back on a claim that already paid.
Whether your practice runs a dedicated infusion suite or you're a rheumatology or oncology office doing regular IV treatments, here's how to get the coding right in 2026.
If you're working through these issues, our specialty billing services can help you address them systematically.
Bill an iron infusion with 96365 for the first hour, plus the drug's J-code per unit: J1756 iron sucrose per 1 mg, J1439 ferric carboxymaltose per 1 mg, or J2916 sodium ferric gluconate per 12.5 mg. A 200 mg iron sucrose dose is 200 units of J1756.
| Drug | HCPCS | 1 billing unit | Example dose |
|---|---|---|---|
| Iron sucrose (Venofer) | J1756 | 1 mg | 200 mg = 200 units |
| Ferric carboxymaltose (Injectafer) | J1439 | 1 mg | 750 mg = 750 units |
| Sodium ferric gluconate (Ferrlecit) | J2916 | 12.5 mg | 125 mg = 10 units |
The unit sizes differ, and that's where claims go wrong. Count units from the dose actually given, not the number of vials. Add JW for any discarded drug and JZ when nothing was wasted, if your payer requires them. Document the dose, the start and stop times, and the diagnosis (iron deficiency anemia, with the specific cause when it's known). Coverage rules for iron products vary by MAC, so check your contractor's policy before you schedule a series.
CMS and most commercial payers require you to sequence infusion services in a specific order. The "primary" service drives everything else. Get the hierarchy wrong and you'll get a bundling denial even when the services were legitimately provided.
The hierarchy, from highest to lowest priority:
Hydration can't be billed as the primary service if a drug infusion happened during the same visit. That's a hard rule. And if you gave chemo, the chemo code is primary, even if the hydration bag went up first.
Where the hierarchy applies matters. Payer policies built on the CPT guidelines apply it in facility settings such as a hospital outpatient department. In a physician office, the initial code is the one that best describes the primary reason for the encounter, whatever order the drugs were given. Check the payer's policy for your place of service.
| CPT | Description | Notes |
|---|---|---|
| 96365 | IV infusion, initial up to 1 hour | Primary code: therapeutic drug |
| 96366 | IV infusion, each additional hour | Add-on to 96365; max based on documented time |
| 96367 | Additional sequential infusion, each drug | Different drug after primary infusion ends |
| 96368 | Concurrent infusion | Different drug running at same time, once per day max |
| 96360 | Hydration, initial 31 min to 1 hour | Only if no therapeutic drug given |
| 96361 | Hydration, each additional hour | Add-on to 96360 |
The time clock starts when the infusion begins, not when the nurse hangs the bag. Documentation needs to capture start and stop times for each drug or fluid. "IVIG started 9:15am, ended 11:45am" is 150 minutes, which gets you 96365 plus one unit of 96366. A second unit of 96366 would need 151 minutes.
Infusions shorter than 15 minutes don't get billed as infusions. They bill as pushes (96374 or 96375). This trips up a lot of practices running short hydration runs or quick antibiotic doses.
| Total infusion time | Codes |
|---|---|
| 16 to 90 minutes | 96365 |
| 91 to 150 minutes | 96365 + 96366 x1 |
| 151 to 210 minutes | 96365 + 96366 x2 |
IV hydration bills as 96360 for the first 31 to 60 minutes and 96361 for each additional hour. It can't be the primary service when a drug infusion happens the same visit. Then only a separate, sequential hydration run over 30 minutes reports 96361; concurrent hydration isn't billable.
| CPT | Description |
|---|---|
| 96413 | Chemo infusion, initial up to 1 hour |
| 96415 | Chemo infusion, each additional hour |
| 96417 | Each additional sequential chemo infusion |
| 96409 | Chemo IV push, single or initial substance |
| 96411 | Each additional chemo IV push |
| 96401 | Chemo subcutaneous or IM injection |
Chemo codes require that the administering nurse or staff member have documented training in chemotherapy administration. Some payers require a specific credential. If your staff isn't documented as trained, your chemo claims will deny, and that's not a coding fix, it's an operations fix.
When a single-dose vial is partially used, the unused portion can be billed. Modifier JW goes on the drug line item to identify the discarded amount. Without it, you can't capture wastage. On expensive biologics (rituximab, infliximab, trastuzumab) that discarded drug can represent hundreds to thousands of dollars per encounter, and it adds up fast across a full infusion schedule.
Modifier JZ is used when there is no waste (the full vial was used). Some payers require one or the other on every drug claim. Check your payer policies: this isn't universal.
Infusion billing works differently depending on where services happen. In a hospital outpatient department or ASC, the facility bills separately from the professional component. In a physician office, you're billing both the drug and the administration on the same claim.
Place of service matters a lot here. An infusion done in a physician office (POS 11) reimburses at a different rate than the same service in a hospital outpatient department (POS 22). And the drug J-codes may or may not be separately reimbursable depending on the setting.
In the buy-and-bill model, your practice purchases the drug, administers it, and bills the payer for both the drug (J-code) and the administration (9XXXX). White bagging means the payer's specialty pharmacy ships the drug directly to you; you still bill for administration but not the drug itself. A growing number of commercial payers are pushing white bagging. Know which of your payers require it before you order drugs you can't bill for.
Nearly every infusion drug requires prior authorization, and the approval is typically drug-specific, not just service-specific. An auth for rituximab doesn't cover infliximab. Many practices run into trouble when a physician switches a patient to a different biologic mid-treatment cycle without getting a new auth.
Build a workflow that checks auth at every encounter, not just at the start of treatment. Drug changes, dose adjustments, and frequency changes can all require a new auth.
Hierarchy and J-code errors are the single biggest source of infusion denials we see, and they compound fast at volume. If your denial rate on infusion claims is climbing, our denial management service traces each one back to root cause instead of just re-filing it. Not sure where you stand? Start with a free revenue assessment of your last 90 days of infusion claims.
See how Rcmaxis handles the full scope of Infusion Therapy billing on our Infusion Therapy billing services page.
Infusion claims are reviewed on three things. First, time: each additional hour and each sequential infusion has to be supported by documented start and stop times, because these codes are time-based. Second, the drug: the drug billed has to match the drug administered, in the units administered, with the National Drug Code and the dose in the record. Third, the sequence: if the hierarchy isn't followed, the claim bundles or pays incorrectly.
Wastage is where audits get specific. The JW modifier identifies discarded drug from a single-dose vial, and Medicare also requires the JZ modifier on single-dose container claims when nothing was discarded. Missing either one invites a review of the whole drug line. Contractors can look back three years, and on a biologic-heavy infusion suite, a 3-year lookback with a recurring wastage-modifier error can put a large recoupment on the table, plus the appeal cost.
Infusion payment is built from time. At 2026 non-facility rates, the first hour (96365) pays $67.14, each additional hour (96366) pays $21.38, an additional sequential infusion (96367) pays $29.73, and an IV push of a new drug (96375) pays $15.70.
A center that runs 40 infusions a week and loses one additional-hour unit on a quarter of them, because the stop time wasn't recorded, gives up $213.80 a week. Over 50 weeks, that's $10,690. The administration codes are small next to the drug, but they're the part that depends entirely on a nurse's time record.
Bill an iron infusion with 96365 for the first hour, plus the drug's J-code per unit: J1756 iron sucrose per 1 mg, J1439 ferric carboxymaltose per 1 mg, or J2916 sodium ferric gluconate per 12.5 mg. A 200 mg iron sucrose dose is 200 units of J1756.
IV hydration bills as 96360 for the first 31 to 60 minutes and 96361 for each additional hour. It can't be the primary service when a drug infusion happens the same visit. Then only a separate, sequential hydration run over 30 minutes reports 96361; concurrent hydration isn't billable.
96366 needs more than 30 minutes beyond each full hour. A 90-minute infusion earns 96365 only. A 91-minute infusion earns one unit of 96366, and a 151-minute infusion earns two.
The article explains that CMS and most commercial payers expect infusion services to be sequenced in a specific order, with a primary service that drives the rest. Sequencing them wrong can produce a bundling denial even when every service was legitimate.
When a single-dose vial is partly used, the discarded amount can be billed by putting modifier JW on the drug line, according to the article. Without it you can't capture the wastage, which matters most on high-cost biologics.
No. The article notes that approvals are usually drug-specific, so an authorization for rituximab doesn't cover infliximab. Check the drug and the dose against the authorization before each series starts.
The billing gaps most practices don't catch until they show up as denials. Get the checklist: free, no spam.
✓ Got it! Your info is saved: view the checklist now →
We don't share your info. Unsubscribe any time.
Our infusion billing specialists review your coding, drug J-codes, and modifier use, and identify exactly where revenue is slipping through the cracks.
Get Your Free Revenue Assessment